Insider Transactions Reported by 15 Insiders of VYNE Therapeutics Inc.

Symbol
VYNE on Nasdaq
Location
Bridgewater, NJ

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

VYNE Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PERCEPTIVE ADVISORS LLC 10%+ Owner $11,251,930 16 Aug 2021
AI Biotechnology LLC 10%+ Owner $2,545,814 01 Nov 2023
Andrew Saik Chief Financial Officer $265,547 28 May 2021
Wiley Matthew T. Chief Commercial Officer $249,081 30 Jun 2021
David Domzalski PRESIDENT AND CEO, Director $241,442 31 Dec 2025
PATRICK G. LEPORE Director $150,298 12 Dec 2025
Mutya Harsch Chief Legal Officer And Gc $73,037 31 Dec 2025
Iain Stuart Chief Scientific Officer $66,850 31 Dec 2025
Tyler Zeronda Chief Financial Officer $60,211 31 Dec 2025
Elisabeth Sandoval Little Director 12 Dec 2025
SHARON BARBARI Director 12 Dec 2025
Rex Bright Director 19 Jul 2021
Anthony D. Bruno Director 12 Dec 2024
Christine Borowski Director 12 Dec 2024
Steven L. Basta Director 12 Dec 2025

Recent Insider Transactions by Companies or Individuals for VYNE Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.